UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

New Score Can Be Used to Assess Hereditary ATTR

Source
Rare Disease Advisor

The modified-comprehensive Kumamoto Score (mKS) can be used as a validated comprehensive tool for the assessment of hereditary transthyretin amyloidosis (ATTR), according to a new study published in Amyloid.

The score also has enhanced early-stage sensitivity and offers independent subscales specific to different organs, therefore addressing critical unmet needs.

To develop and validate mKS, a team of researchers led by Mitsuharu Ueda, MD, from Kumamoto University in Japan conducted a prospective study of 76 patients with genetically confirmed ATTR. The median age of patients was 56.2 years, and the majority (60.5% of all patients) had the Val30Met mutation.